Skip to main content
. 2025 Jul 1;51(6-7):223–237. doi: 10.14745/ccdr.v51i67a02

Table 1. Estimated chronic hepatitis B prevalence for the general population and key populations, Canada, 2021.

Population Population size estimate Prevalence (%) Estimated number of people living with CHB Reference(s)
Point estimate Lower bound Upper bound Point estimate Lower bound Upper bound
General population 38,239,864 0.68% 0.40% 0.97% 262,000 152,000 371,000 ((12,14,2124))
Immigrants from countries where HBV is common (HBsAg ≥2%) 5,599,485 4.2% 1.9% 5.6% 237,000 106,000 312,000 ((21,25,26))
GBMSM 669,613 1.4% 0.8% 2.1% 9,310 5,360 14,100 ((27,28))
Unpublished data from the Engage cohort study, 2017–2019
People incarcerated in federal prisonsa 12,405 0.28% 0.19% 0.41% 35 24 51 Unpublished data from Correctional Service Canada, 2021 (personal communication, 2024)
People incarcerated in provincial prisonsb Insufficient information
PWID Insufficient information
First Nations Insufficient information
Inuit Insufficient information
Métis Insufficient information

Abbreviations: CHB, chronic hepatitis B; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; GBMSM, gay, bisexual and other men who have sex with men; PWID, people who inject drugs

a Who were sentenced for two years or more

b Who were sentenced for less than two years